Efinaconazole side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Efinaconazole. Common side effects include abdominal pain upper among females and tubulointerstitial nephritis among males.
The phase IV clinical study is created by eHealthMe based on 135 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
135 people who take Efinaconazole and have side effects are studied.
What is Efinaconazole?
Efinaconazole has active ingredients of efinaconazole. eHealthMe is studying from 136 Efinaconazole users for its effectiveness, alternative drugs and more.
Number of Efinaconazole reports submitted per year:

Efinaconazole side effects by time on the drug *:
Efinaconazole side effects by gender *:
Efinaconazole side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Efinaconazole?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on efinaconazole (the active ingredients of Efinaconazole) and Efinaconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Efinaconazole:
- Efinaconazole (136 reports)
All Efinaconazole side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Heparin and Electrocardiogram T Wave Amplitude Decreased - now
- Invega vs. 5 Htp - 6 seconds ago
- Provera and Glutathione drug interaction - 6 seconds ago
- Protonix and Skin Blushing/Flushing - 10 seconds ago
- Doxycycline and Varicose Veins - 11 seconds ago
- Aerobid and Combivent drug interaction - 12 seconds ago
- Vitamin K1 and Hepatic Function Abnormal - 17 seconds ago
- Clopidogrel and Mitigare drug interaction - 23 seconds ago
- Cidofovir and Scopolamine drug interaction - 24 seconds ago
- 5 Htp vs. Lamotrigine - 32 seconds ago